231 related articles for article (PubMed ID: 29951044)
21. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
[TBL] [Abstract][Full Text] [Related]
22. Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance.
Sakihama S; Karube K
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625999
[TBL] [Abstract][Full Text] [Related]
23. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
Ohshima K; Suzumiya J; Kikuchi M
Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
[TBL] [Abstract][Full Text] [Related]
24. Random integration of HTLV-1 provirus: increasing chromosomal instability.
Ohshima K; Ohgami A; Matsuoka M; Etoh K; Utsunomiya A; Makino T; Ishiguro M; Suzumiya J; Kikuchi M
Cancer Lett; 1998 Oct; 132(1-2):203-12. PubMed ID: 10397475
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma.
Yamada Y; Kamihira S
Leuk Lymphoma; 2005 Nov; 46(11):1553-9. PubMed ID: 16236609
[TBL] [Abstract][Full Text] [Related]
26. Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina.
Marin O; Hasui K; Remondegui C; Sato E; Aye MM; Takenouchi N; Izumo S; Tajima K
Pathol Int; 2002; 52(5-6):348-57. PubMed ID: 12100517
[TBL] [Abstract][Full Text] [Related]
27. Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.
Ramezani S; Shirdel A; Rafatpanah H; Akbarin MM; Tarokhian H; Rahimi H; Bari A; Jahantigh HR; Rezaee SA
Med Microbiol Immunol; 2017 Aug; 206(4):327-335. PubMed ID: 28466382
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic, immunophenotypic and ultrastructrual analyses of ATLL patients with cutaneous involvement.
Wang C; Yao Z; Liao J; Luo Y; Ma Y; Chen G; Zhu W
Chin Med J (Engl); 1999 May; 112(5):461-5. PubMed ID: 11593520
[TBL] [Abstract][Full Text] [Related]
29. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice.
Liu Y; Dole K; Stanley JR; Richard V; Rosol TJ; Ratner L; Lairmore M; Feuer G
Leuk Res; 2002 Jun; 26(6):561-7. PubMed ID: 12007504
[TBL] [Abstract][Full Text] [Related]
30. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
31. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Int J Cancer; 2003 Sep; 106(5):706-12. PubMed ID: 12866030
[TBL] [Abstract][Full Text] [Related]
32. Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues.
Shimizu-Kohno K; Satou Y; Arakawa F; Kiyasu J; Kimura Y; Niino D; Sugita Y; Ishikawa F; Matsuoka M; Ohshima K
Cancer Sci; 2011 Jul; 102(7):1432-6. PubMed ID: 21453388
[TBL] [Abstract][Full Text] [Related]
33. T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases.
Pombo de Oliveira MS; Matutes E; Schulz T; Carvalho SM; Noronha H; Reaves JD; Loureiro P; Machado C; Catovsky D
Int J Cancer; 1995 Mar; 60(6):823-7. PubMed ID: 7896453
[TBL] [Abstract][Full Text] [Related]
34. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
Arnulf B; Thorel M; Poirot Y; Tamouza R; Boulanger E; Jaccard A; Oksenhendler E; Hermine O; Pique C
Leukemia; 2004 Jan; 18(1):126-32. PubMed ID: 14574331
[TBL] [Abstract][Full Text] [Related]
35. Absence of FLT3 mutations in Iranian adult T-cell leukemia/lymphoma patients.
Ayatollahi H; Sadeghian M; Kooshyar M; Shirdel A; Rahimi H; Jafarian A; Ghazaei S; Soltani N; Shams F; Motamedi Rad N; Shakeri S
Med J Islam Repub Iran; 2018; 32():47. PubMed ID: 30159298
[No Abstract] [Full Text] [Related]
36. Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma.
Shimakage M; Inoue N; Ohshima K; Kawahara K; Yamamoto N; Oka T; Tambe Y; Yasui K; Matsumoto K; Yutsudo M; Inoue H
Int J Oncol; 2007 Jun; 30(6):1343-8. PubMed ID: 17487354
[TBL] [Abstract][Full Text] [Related]
37. Collagen IV (COL4A1, COL4A2), a Component of the Viral Biofilm, Is Induced by the HTLV-1 Oncoprotein Tax and Impacts Virus Transmission.
Millen S; Gross C; Donhauser N; Mann MC; Péloponèse JM; Thoma-Kress AK
Front Microbiol; 2019; 10():2439. PubMed ID: 31708905
[TBL] [Abstract][Full Text] [Related]
38. Adult T-cell leukemia/lymphoma.
Rasul KI; Barwari ZA
Gulf J Oncolog; 2012 Jul; (12):27-37. PubMed ID: 22773213
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
40. Efficiency of AUY922 in mice with adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Oncol Lett; 2016 Jul; 12(1):387-392. PubMed ID: 27347156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
